ÍøºìºÚÁÏ

Skip to main content

R. David Anderson, MD, MS, FACC, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 17 publications
  • Coronary Artery Disease , 15 publications
  • Coronary Circulation , 10 publications

Research activity

115 publications

7,441 citations

Why is this important?

Active clinical trials

SMART

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Cardiamp CMI

Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
21 Years - 80 Years
Sexes
All

My publications

115 publications

2020

Incidence, Clinical Presentation, and Causes of 30-Day Readmission Following Hospitalization With Spontaneous Coronary Artery Dissection.

JACC. Cardiovascular interventions

•

2020

Myocardial infarction and persistent angina with no obstructive coronary artery disease

2020

Percutaneous inferior vena cava valve implantation may improve tricuspid valve regurgitation and cardiac output: Lessons learned

Innovations (Philadelphia, Pa. Online)

2020

Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.

International journal of cardiology

•

2019

Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials

Cardiovascular revascularization medicine : including molecular interventions